Brief: Akoustis Technologies Reports Q4 Results
12/09/2022 12:08
Sept 12 (Reuters) - Akoustis Technologies Inc AKTS.O :
* AKOUSTIS REPORTS THIRD CONSECUTIVE QUARTER OF RECORD
REVENUE AS
FOURTH QUARTER FISCAL 2022 SALES GREW BY OVER 140%
YEAR-OVER-YEAR
* AKOUSTIS TECHNOLOGIES INC QUARTERLY REVENUE ROSE 140
PERCENT TO
$5.2 MILLION
* AKOUSTIS TECHNOLOGIES INC - QTRLY ADJUSTED LOSS PER SHARE
$0.26
Source text for Eikon: ID:nGNX5PW0pN
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut